OBIO EPS Estimates
Orchestra BioMed Holdings, Inc.
$5.64
-$0.08(-1.40%)
50
Overall
60
Value
66
Tech
26
Quality
Market Cap
$338.99M
Volume
222.88K
52W Range
$3.06 - $6.50
Target Price
$12.50
OBIO EPS estimates: the consensus estimate for Orchestra BioMed Holdings, Inc.'s current fiscal year is -$1.53 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
OBIO EPS Estimates
- EPS estimate, current quarter
- $-0.40
- EPS estimate, next quarter
- $-0.42
- EPS estimate, current year
- $-1.53
- EPS estimate, next year
- $-1.45
- EPS growth, 3-year
- -86.91%
| Fiscal year | EPS |
|---|---|
| 2025 | $-1.11 |
| 2024 | $-1.66 |
| 2023 | $-1.48 |
| 2022 | $-0.17 |
| 2021 | $-0.02 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | OBIO | $5.64 | -1.4% | 222.88K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Orchestra BioMed Holdings, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW